Literature DB >> 33188070

Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function.

Maximilian Brinkhaus1, Ruben G J Douwes1, Arthur E H Bentlage1, A Robin Temming1, Steven W de Taeye1,2, Matthias Tammes Buirs1, Jacoline Gerritsen1, Juk Yee Mok3, Giso Brasser3, Peter C Ligthart4, Wim J E van Esch3, Peter Verheesen5, Hans de Haard5, Theo Rispens2, Gestur Vidarsson6.   

Abstract

Abs of the IgG isotype mediate effector functions like Ab-dependent cellular cytotoxicity and Ab-dependent cellular phagocytosis by Fc interactions with FcγRs and complement-dependent cytotoxicity upon IgG-Fc binding to C1q. In this study, we describe the crucial role of the highly conserved dual glycines at position 236-237 in the lower hinge region of human IgG, including the lack of one glycine as found in IgG2. We found several permutations in this region that either silence or largely abrogate FcγR binding and downstream FcγR effector functions, as demonstrated by surface plasmon resonance, Ab-dependent cellular phagocytosis, and Ab-dependent cellular cytotoxicity assays. Although the binding regions of FcγRs and C1q on the IgG-Fc largely overlap, IgG1 with a deletion of G236 only silences FcγR-mediated effector functions without affecting C1q-binding or activation. Several mutations resulted in only residual FcγRI binding with differing affinities that are either complement competent or silenced. Interestingly, we also found that IgG2, naturally only binding FcγRIIa, gains binding to FcγRI and FcγRIIIa after insertion of G236, highlighting the crucial importance of G236 in IgG for FcγR interaction. These mutants may become invaluable tools for FcγR-related research as well as for therapeutic purposes in which only complement-mediated functions are required without the involvement of FcγR.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33188070     DOI: 10.4049/jimmunol.2000961

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro.

Authors:  A Robin Temming; Matthias Tammes Buirs; Arthur E H Bentlage; Louise W Treffers; Hannah Feringa; Steven W de Taeye; Taco W Kuijpers; Sietse Q Nagelkerke; Giso Brasser; Juk Yee Mok; Wim J E van Esch; Timo K van den Berg; Theo Rispens; C Ellen van der Schoot; Gestur Vidarsson
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

2.  Human IgE does not bind to human FcRn.

Authors:  Maximilian Brinkhaus; Elvera J van der Kooi; Arthur E H Bentlage; Pleuni Ooijevaar-de Heer; Ninotska I L Derksen; Theo Rispens; Gestur Vidarsson
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

3.  An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH.

Authors:  Yutong Liu; Alison G Lee; Annalee W Nguyen; Jennifer A Maynard
Journal:  J Biol Chem       Date:  2022-03-03       Impact factor: 5.157

4.  The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement.

Authors:  Maximilian Brinkhaus; Erwin Pannecoucke; Elvera J van der Kooi; Arthur E H Bentlage; Ninotska I L Derksen; Julie Andries; Bianca Balbino; Magdalena Sips; Peter Ulrichts; Peter Verheesen; Hans de Haard; Theo Rispens; Savvas N Savvides; Gestur Vidarsson
Journal:  Nat Commun       Date:  2022-10-14       Impact factor: 17.694

5.  Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing.

Authors:  Dieke J van Rees; Maximilian Brinkhaus; Bart Klein; Paul Verkuijlen; Anton T J Tool; Karin Schornagel; Louise W Treffers; Michel van Houdt; Arnon P Kater; Gestur Vidarsson; Andrew R Gennery; Taco W Kuijpers; Robin van Bruggen; Hanke L Matlung; Timo K van den Berg
Journal:  Blood Adv       Date:  2022-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.